|
시장보고서
상품코드
2055311
HTS(High Throughput Screening) 시장 : 제품 및 서비스별, 기술별, 용도별, 최종사용자별, 지역별High Throughput Screening Market, By Product and Services, By Technology, By Application, By End User, By Geography |
||||||
HTS(High Throughput Screening) 시장은 2026년 289억 7,000만 달러로 추정되며, 2033년까지 597억 6,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 10.9%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 289억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.90% | 2033년 시장 규모 예측 : | 597억 6,000만 달러 |
세계 HTS(High Throughput Screening) 시장은 제약 및 생명공학 산업에서 매우 중요한 분야로, 자동화된 스크리닝 기술을 통해 신약 개발 및 연구 과정에 혁신을 가져오고 있습니다. 고속 스크리닝을 통해 연구자들은 수백만 건에 달하는 화학적, 유전적, 또는 약리학적 실험을 신속하게 수행할 수 있게 되어, 특정 생체 분자 경로를 조절하는 활성 화합물, 항체 또는 유전자의 규명을 크게 가속화합니다. 이러한 첨단 조사 기법은 현대 제약 연구에서 필수적인 요소로 자리 잡았으며, 연구 기관이 방대한 화합물 라이브러리를 전례 없는 속도와 효율성으로 처리할 수 있게 해줍니다.
이 기술에는 세포 기반 분석, 생화학적 분석, 표현형 스크리닝 등 각각 다른 연구 목적을 달성하는 다양한 스크리닝 플랫폼이 포함됩니다. 제약 기업들이 엄격한 안전성 및 유효성 기준을 유지하면서도 의약품 개발 기간 단축이라는 점점 더 커지는 압박에 직면한 가운데, HTS(High Throughput Screening)(HTS) 기술은 혁신을 실현하는 핵심 요소로 부상했습니다. 이 시장에는 액체 처리 시스템 및 검출 시스템과 같은 하드웨어 구성 요소 외에도, 데이터 분석과 실험실 자동화를 통합하는 소프트웨어 솔루션이 포함됩니다. 생물학적 표적의 복잡성 증가와 더불어, 맞춤형 의료 및 정밀의료에 대한 수요가 높아짐에 따라, 현대 의약품 연구개발 생태계에서 HTS(High Throughput Screening) 플랫폼의 중요성은 더욱 커지고 있습니다.
시장 역학
세계 HTS(High Throughput Screening) 시장은 제약 연구의 양상을 지속적으로 변화시키고 있는 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 주요 촉진요인은 기존 신약 개발 방식에 따른 비용 상승과 개발 기간의 장기화에 있으며, 제약 기업들은 수백만 개의 화합물을 효율적으로 처리할 수 있는 자동 스크리닝 기술을 도입할 수밖에 없는 상황입니다. 암, 신경계 질환, 대사성 질환을 포함한 만성 질환의 유병률 증가는 새로운 치료제 후보 물질에 대한 수요를 높임으로써, HTS 플랫폼에 대한 투자를 촉진하고 있습니다. 또한, 맞춤형 의료와 정밀 치료에 대한 관심이 높아지는 가운데, 다양한 분자 표적에 대한 종합적인 스크리닝이 필요해지고 있으며, 이는 시장 확대를 더욱 촉진하고 있습니다.
자동화, 소형화 및 검출 시스템 분야의 기술적 진보로 인해 선별 능력이 크게 향상되고 운영 비용이 절감되었습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 그 중 하나는 HTS 시설 구축에 필요한 막대한 초기 투자 비용으로, 이는 소규모 생명공학 기업이나 학술 기관에게 장벽이 되고 있습니다. 또한, 고처리량 실험에서 얻어지는 데이터의 관리와 분석은 복잡하며, 전문적인 지식과 고도의 소프트웨어 솔루션이 필요하기 때문에 운영상의 추가적인 과제가 발생하고 있습니다. 게다가 높은 유지비와 지속적인 기술 업그레이드의 필요성은 조직의 예산을 압박할 수 있습니다. 이러한 과제가 있음에도 불구하고, 스크리닝 프로토콜의 최적화와 데이터 분석 능력 향상을 가능하게 하는 인공지능(AI) 및 머신러닝 기술의 통합을 통해 큰 기회가 창출되고 있습니다. 기존의 제약 연구에 그치지 않고, 농업 생명공학, 화장품, 환경 모니터링 등의 분야로 HTS의 적용 범위가 확대되고 있는 것은 유망한 성장 기회를 시사합니다.
본 조사의 주요 특징.
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 전 세계 HTS(High Throughput Screening) 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 ‘고속 스크리닝’ 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 HTS(High Throughput Screening) 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 HTS(High Throughput Screening) 시장 : 제품 및 서비스별, 2021년-2033년
제5장 세계의 HTS(High Throughput Screening) 시장 : 기술별, 2021년-2033년
제6장 세계의 HTS(High Throughput Screening) 시장 : 용도별, 2021년-2033년
제7장 세계의 HTS(High Throughput Screening) 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 HTS(High Throughput Screening) 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
LSHHigh Throughput Screening Market is estimated to be valued at USD 28.97 Bn in 2026 and is expected to reach USD 59.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.90% | 2033 Value Projection: | USD 59.76 Bn |
The global high throughput screening market represents a pivotal segment within the pharmaceutical and biotechnology industry, revolutionizing drug discovery and development processes through automated screening technologies. High throughput screening enables researchers to rapidly conduct millions of chemical, genetic, or pharmacological tests, significantly accelerating the identification of active compounds, antibodies, or genes that modulate particular biomolecular pathways. This sophisticated methodology has become indispensable in modern pharmaceutical research, allowing organizations to process vast libraries of compounds with unprecedented speed and efficiency.
The technology encompasses various screening platforms including cell-based assays, biochemical assays, and phenotypic screening, each serving distinct research objectives. As pharmaceutical companies face mounting pressure to reduce drug development timelines while maintaining rigorous safety and efficacy standards, High Throughput Screening (HTS) technologies have emerged as critical enablers of innovation. The market encompasses hardware components such as liquid handling systems, detection systems, and software solutions that integrate data analysis and laboratory automation. The increasing complexity of biological targets, coupled with the growing demand for personalized medicine and precision therapeutics, has further amplified the significance of high throughput screening platforms in contemporary pharmaceutical research and development ecosystems.
Market Dynamics
The global high throughput screening market is propelled by several compelling drivers that continue to reshape the pharmaceutical research landscape. The primary driver stems from the escalating costs and extended timelines associated with traditional drug discovery methods, compelling pharmaceutical companies to adopt automated screening technologies that can process millions of compounds efficiently. The increasing prevalence of chronic diseases, including cancer, neurological disorders, and metabolic conditions, has intensified the demand for novel therapeutic compounds, thereby driving investment in HTS platforms. Additionally, the growing emphasis on personalized medicine and precision therapeutics necessitates comprehensive screening of diverse molecular targets, further fueling market expansion.
Technological advancements in automation, miniaturization, and detection systems have significantly enhanced screening capabilities while reducing operational costs. However, the market faces notable restraints including the substantial initial capital investment required for establishing HTS facilities, which poses barriers for smaller biotechnology companies and academic institutions. The complexity of data management and analysis from high-throughput experiments requires specialized expertise and sophisticated software solutions, creating additional operational challenges. Furthermore, the high maintenance costs and the need for continuous technological upgrades can strain organizational budgets. Despite these challenges, significant opportunities emerge from the integration of artificial intelligence and machine learning technologies that can optimize screening protocols and enhance data interpretation. The expanding application of HTS beyond traditional pharmaceutical research into areas such as agricultural biotechnology, cosmetics, and environmental monitoring presents lucrative growth prospects.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global high throughput screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity (formerly PerkinElmer), Agilent Technologies (including BioTek), Danaher (Molecular Devices), Beckman Coulter Life Sciences, Tecan Group, Hamilton Company, BMG LABTECH, Yokogawa Electric (CellVoyager), SPT Labtech, HighRes Biosolutions, Aurora Biomed, Eppendorf, Sartorius (ForteBio Octet), and Azenta Life Sciences (formerly Brooks Life Sciences)
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global high throughput screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high throughput screening market
Market Segmentation
- Product And Services Insights (Revenue, USD Bn, 2021 - 2033)
- Instruments (Liquid Handling Systems, Detectors and Readers)
- Reagents and Consumables (Assay Kits, Reagents and Chemicals)
- Software and Services
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Cell-based Assays
- Biochemical Assays
- Label-free Technology
- Lab-on-a-Chip (LOC) and Microfluidics
- Ultra-high Throughput Screening (uHTS)
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Drug Discovery
- Toxicology Screening
- Genomics and Proteomics Research
- Biochemical Pathway Analysis
- Target Identification and Validation
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Government and Regulatory Agencies
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific
- Revvity (formerly PerkinElmer)
- Agilent Technologies (including BioTek)
- Danaher (Molecular Devices)
- Beckman Coulter Life Sciences
- Tecan Group
- Hamilton Company
- BMG LABTECH
- Yokogawa Electric (CellVoyager)
- SPT Labtech
- HighRes Biosolutions
- Aurora Biomed
- Eppendorf
- Sartorius (ForteBio Octet)
- Azenta Life Sciences (formerly Brooks Life Sciences)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global High Throughput Screening Market, By Product and Services
- Global High Throughput Screening Market, By Technology
- Global High Throughput Screening Market, By Application
- Global High Throughput Screening Market, By End User
- Global High Throughput Screening Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global High Throughput Screening Market, By Product and Services, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Instruments (Liquid Handling Systems, Detectors and Readers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Reagents and Consumables (Assay Kits, Reagents and Chemicals)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global High Throughput Screening Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cell-based Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biochemical Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Label-free Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lab-on-a-Chip (LOC) and Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ultra-high Throughput Screening (uHTS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global High Throughput Screening Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Toxicology Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genomics and Proteomics Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biochemical Pathway Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Target Identification and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global High Throughput Screening Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government and Regulatory Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global High Throughput Screening Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive landscape
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revvity (formerly PerkinElmer)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies (including BioTek)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher (Molecular Devices)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter Life Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tecan Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hamilton Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BMG LABTECH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yokogawa Electric (CellVoyager)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SPT Labtech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HighRes Biosolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurora Biomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius (ForteBio Octet)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Azenta Life Sciences (formerly Brooks Life Sciences)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us
